Fundz

Bio N Tech Se reported raising $250 Million in an initial SEC Form D filing, from an offering of $250 Million

PUBLIC · BNTXSep 17, 2020

Amount Raised

$250 Million

$250 Million sold, per SEC Form D (first sale Sep 17, 2020)

Round Type

Venture

MainzBiotechnologyHealth CareTherapeuticsBiopharma

Quick answer

BioNTech raised $250 Million in a funding round, dated September 17, 2020. BioNTech is based in Mainz, Rhineland Palatinate, Germany.

How much did BioNTech raise?
BioNTech raised $250 Million in a funding round on September 17, 2020.
What does BioNTech do?
BioNTech is a biopharmaceutical company dedicated to harnessing the power of the immune system to develop innovative cancer therapies and treatments for other serious diseases.
Where is BioNTech based and how big is it?
BioNTech is based in Mainz, Rhineland Palatinate, Germany. Fundz records about 5,000 employees.
Who are the decision-makers at BioNTech?
Fundz holds 1 contact at BioNTech, including the Vice President US Medical Affairs. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as BioNTech that raised within 45 days of this round, from Fundz verified event records.

  • AbSci Corp raised $65M on October 30, 2020.
  • Nuvation Bio raised $275M on October 20, 2020.
  • HCW Biologics raised $6.2M on October 19, 2020.
  • Oragenics raised an undisclosed amount (Funding Round) on September 28, 2020.
  • LAVA Therapeutics raised $83M (Series C) on September 17, 2020.
  • Adipo Therapeutics raised $1.3M (Seed) on September 2, 2020.

Who to call at BioNTech, and when

A new round usually means BioNTech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioNTech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioNTech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioNTech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioNTech

Location

Mainz, Rhineland Palatinate, Germany

About

BioNTech is a biopharmaceutical company dedicated to harnessing the power of the immune system to develop innovative cancer therapies and treatments for other serious diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioNTech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsLuca D., Vice President US Medical Affairs hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for BioNTech's next move

See what Strategic adds

BioNTech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.